Twist Bioscience to Present at Upcoming Investor Conferences
February 22 2024 - 7:00AM
Business Wire
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling
customers to succeed through its offering of high-quality synthetic
DNA using its silicon platform, today announced that its executives
will participate in fireside chats at the following upcoming
investor conferences:
- Patrick Finn, Ph.D., president and COO, and Adam Laponis, CFO,
will participate in a fireside chat at the TD Cowen 44th Annual
Health Care Conference on Tuesday, March 5 in Boston, MA; fireside
chat at 11:10 a.m. Eastern Time.
- Emily Leproust, Ph.D., CEO and co-founder, and Adam Laponis,
CFO, will participate in a fireside chat at the Barclays 26th
Annual Global Healthcare Conference on Tuesday, March 12 in Miami,
FL; fireside chat at 7:30 a.m. Eastern Time.
The fireside chats will be webcast live and can be accessed by
visiting the “Investor Calendar” page of the investor relations
section of the company's website here. A replay of the fireside
chats will be archived for a period of 30 days following the
conclusion of the live events.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic
biology and genomics company that has developed a disruptive DNA
synthesis platform to industrialize the engineering of biology. The
core of the platform is a proprietary technology that pioneers a
new method of manufacturing synthetic DNA by “writing” DNA on a
silicon chip. Twist is leveraging its unique technology to
manufacture a broad range of synthetic DNA-based products,
including synthetic genes, tools for next-generation sequencing
(NGS) preparation, and antibody libraries for drug discovery and
development. Twist is also pursuing longer-term opportunities in
digital data storage in DNA and biologics drug discovery. Twist
makes products for use across many industries including healthcare,
industrial chemicals, agriculture and academic research.
Follow us on Twitter | Facebook | LinkedIn | YouTube |
Instagram
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240222694551/en/
For Investors: Angela Bitting SVP, Corporate Affairs
925-202-6211 abitting@twistbioscience.com For Media: Amanda
Houlihan Communications Manager 774-265-5334
ahoulihan@twistbioscience.com
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Apr 2024 to May 2024
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From May 2023 to May 2024